| Literature DB >> 33297455 |
Silvia Lai1, Maria Ida Amabile1, Sandro Mazzaferro2, Giovanni Imbimbo1, Anna Paola Mitterhofer1, Alessandro Galani3, Filippo Aucella4, Giuliano Brunori5, Paolo Menè6, Alessio Molfino1.
Abstract
The prevalence of renal disease is constantly increasing in older adults and a prognostic evaluation by a valid tool may play a key role in treatment management. We aimed to assess the association(s) between the multidimensional prognostic index (MPI) and both the hospitalization and mortality among older adults with renal disease. Patients with chronic kidney disease (CKD) (stage 3-5 KDOQI) and on dialysis were considered. Clinical parameters were registered at baseline and after 2 years. In all the patients, the MPI was calculated and divided into grade 0 (low risk), 1 (moderate risk), and 2 (severe risk). Hospitalizations and mortality were recorded during the follow-up and analyzed according to MPI grade. A total of 173 patients, with a median age of 76 years, on conservative (n = 105) and replacement therapy (32 patients on hemodialysis, 36 patients on peritoneal dialysis) were enrolled. Of them, 60 patients were in MPI grade 0, 102 in grade 1, and 11 in grade 2. The median duration of all the hospitalizations was 6 days and the number of deaths was 33. MPI significantly correlated with days of hospitalization (r = 0.801, p < 0.00001) and number of hospitalizations per year (r = 0.808, p < 0.00001), which was higher in MPI grade 2 compared to grade 1 (p < 0.001) and to grade 0 (p < 0.001). We found a significant association between MPI grades and mortality (p < 0.001). Our results indicate that MPI was associated with outcomes in patients with renal disease, suggesting that a multidimensional evaluation should be implemented in this clinical setting.Entities:
Keywords: chronic kidney disease; hemodialysis; hospitalization; mortality; multidimensional prognostic index; peritoneal dialysis
Year: 2020 PMID: 33297455 PMCID: PMC7762388 DOI: 10.3390/jcm9123965
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241